Beam Therapeutics Inc share price logo

Beam Therapeutics Inc Share Price

NASDAQ: BEAM

Mid Cap

$20.59

-0.96

(-4.43%)

as on

Beam Therapeutics Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $20.52
    $21.43
    downward going graph

    0.34%

    Downside

    4.08%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $13.53
    $35.25
    downward going graph

    34.31%

    Downside

    71.20%

    Upside

    downward going graph

Beam Therapeutics Inc share price movements today

Previous Close
$21.55
Open
$21.27
Volume
1.9M
Day's Low - High
$20.52 - $21.43
52 Week Low - High
$13.53 - $35.25

Beam Therapeutics Inc Historical Returns

1 Month Return
+ 17.58 %
3 Month Return
+ 20.75 %
1 Year Return
-21.67 %
3 Year Return
-61.37 %
5 Year Return
0 %

Beam Therapeutics Inc Stock Fundamentals & Key Indicators

Check Beam Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

-4.3004

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-15.47

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

0

EBITDA

-424.0M

Revenue (TTM)

60.3M

Profit Margin

0.00%

Return On Equity TTM

147449300.00%

Beam Therapeutics Inc Stock Valuation

Track how Beam Therapeutics Inc P/E has moved over time to understand its valuation trends.

Beam Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 13, 2025

Today (-15.47x)

September 13, 2025

Industry (10.13x)

September 13, 2025

Highest (0.00x)

September 13, 2025

LowHigh

Today’s Price to Earnings Ratio: -15.47x

Beam Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beam Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.1BNA-15.470.00%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Beam Therapeutics Inc Stock including INR - Dollar returns

The Beam Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Beam Therapeutics Inc investment value today

Current value as on today

₹83,428

Returns

₹16,572

(-16.57%)

Returns from Beam Therapeutics Inc Stock

₹21,711 (-21.71%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Beam Therapeutics Inc Stock

Based on 21 analysts

BUY

61.90%

Buy

38.10%

Hold

0.00%

Sell

Based on 21 analysts, 61.9% of analysts recommend a 'BUY' rating for Beam Therapeutics Inc. Average target price of $45.92

Beam Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Beam Therapeutics Inc.

What analysts predicted

55.16%UPSIDE

Target Price

$45.92

Current Price

$20.59

Analyzed by

21 Analysts

Target

$45.92

Beam Therapeutics Inc target price $45.92, a slight upside of 55.16% compared to current price of $20.59. According to 21 analysts rating.

Beam Therapeutics Inc Stock's Interest Amongst Investors

Investment in Beam Therapeutics Inc Shares on INDmoney has dropped by -52.95% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-52.95% versus previous 30 day period

Search interest for Beam Therapeutics Inc Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-63% versus previous 30 day period

Beam Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
24
20
17
316
7
11
14
30
7
8
Gross Profit
17
12
9
310
1
6
8
-16
7
2
Operating Income
-98
-102
-108
132
-104
-104
-106
-100
-119
-120
EBITDA
-94
-97
-103
138
-98
-99
-101
-84
-113
-96
Interest Expense
9
11
12
12
-
14
12
-
-
12
Depreciation
4
4
5
5
5
5
5
15
5
5
Income Before Tax
-96
-82
-96
144
-98
-91
-96
-90
-109
-102
Income Tax Expense
-12
-24
-17
1
5
0
-5
-
-
-
Net Income
-84
-82
-96
142
-98
-91
-96
-90
-109
-102
Net Profit Margin
-347.12%
-411.49%
-558.88%
45.16%
-1331.57%
-773.45%
-677.47%
-300.51%
-1462.78%
-1208.26%

Beam Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
0
0
51
60
377
63
Gross Profit
0
-5
-103
35
38
-59
63
Operating Income
-45
-75
-132
-392
-338
-176
-415
EBITDA
-45
-71
-128
-392
-324
-156
-383
Interest Expense
-
0
1
0
15
46
49
Depreciation
0
3
4
7
14
18
31
Income Before Tax
-116
-78
-194
-370
-260
-131
-376
Income Tax Expense
-70
0
61
-29
3
1
0
Net Income
-115
-78
-256
-341
-263
-132
-376
Net Profit Margin
0.00%
-435788.89%
-1068433.33%
-658.44%
-432.68%
-35.09%
-593.13%

Beam Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-82
-96
142
-98
-91
-96
-90
-109
-102
Operating Cash Flow
-84
-89
135
-99
-83
-88
-76
-103
-76
Investing Cash Flow
-41
-10
98
-53
87
24
126
-125
-170
Financing Cash Flow
107
36
33
2
0
1
3
473
1
Change in Cash
-18
-63
266
-148
4
-56
53
244
-245

Beam Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-116
-78
-194
-370
-289
-132
-376
Operating Cash Flow
-20
-72
-95
-66
22
-149
-347
Investing Cash Flow
-13
-66
-100
-294
-461
71
185
Financing Cash Flow
179
41
322
756
111
276
7
Change in Cash
146
-97
126
395
-327
199
-154

Global Institutional Holdings in Beam Therapeutics Inc

Funds
Holdings
Farallon Capital Management, L.L.C.
9.87%
Vanguard Group Inc
8.82%
ARK Investment Management LLC
8.43%
BlackRock Inc
8.06%
FMR Inc
7.88%

Insights on Beam Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BEAM stock has moved up by 16.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -109.27M → -102.29M (in $), with an average increase of 6.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 7.47M → 8.46M (in $), with an average increase of 11.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 187.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 97.4%

About Beam Therapeutics Inc

beam therapeutics is developing precision genetic medicines for serious diseases. co-founded by scientific pioneers known for advancing crispr gene editing, we’re the first company to pursue development of new therapies using crispr base editing technology. we aim to use these technologies to generate a broad pipeline of precision genetic medicines that repair disease-causing point mutations, write in protective genetic variations, or modulate the expression or function of disease-causing genes. who we are beam is creating precision genetic medicines through base editing why we do it our dream is to provide life-long cures for patients suffering from serious diseases who we are and how we work together the beam team:  a community of fearless innovators  rigorous and honest in our research  listening with open minds  committed to each other
OrganisationBeam Therapeutics Inc
Headquarters238 Main Street, Cambridge, MA, United States, 02142
IndustryHealth Technology
CEOMr. John M. Evans M.B.A.
E-voting on sharesClick here to vote

Key Management of Beam Therapeutics Inc

Name

Title

Mr. Sravan Kumar Emany

Chief Financial Officer

Dr. Christine P. Bellon J.D., Ph.D.

Senior VP, Chief Legal Officer & Corporate Secretary

Dr. David R. Liu Ph.D.

Co-Founder

Dr. Manmohan Singh Ph.D.

Chief Technology Officer

Dr. Gopi Shanker Ph.D.

Chief Scientific Officer

Mr. John M. Evans M.B.A.

CEO & Director

Dr. Giuseppe Ciaramella Ph.D.

President

Dr. Amy Simon M.D.

Chief Medical Officer

Dr. Feng Zhang Ph.D.

Co-Founder

Dr. J. Keith Joung M.D., Ph.D.

Co-Founder

FAQs

What is Beam Therapeutics Inc share price today?

Beam Therapeutics Inc share price today is $20.59 as on at the close of the market. Beam Therapeutics Inc share today touched a day high of $21.43 and a low of $20.52.

What is the 52 week high and 52 week low for Beam Therapeutics Inc share?

Beam Therapeutics Inc share touched a 52 week high of $35.25 on and a 52 week low of $13.53 on . Beam Therapeutics Inc stock price today i.e. is closed at $20.59,which is 41.59% down from its 52 week high and 52.24% up from its 52 week low.

What is Beam Therapeutics Inc's market capitalisation today?

Beam Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Beam Therapeutics Inc Stock (BEAM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Beam Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Beam Therapeutics Inc Shares that will get you 0.0729 shares as per Beam Therapeutics Inc share price of $20.59 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Beam Therapeutics Inc Stock (BEAM) from India?

Indian investors can start investing in Beam Therapeutics Inc (BEAM) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Beam Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Beam Therapeutics Inc share’s latest price of $20.59 as on September 13, 2025 at 1:29 am IST, you will get 0.4857 shares of Beam Therapeutics Inc. Learn more about fractional shares .